Elicora, A. Et Al. 2024. Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy.. JOURNAL OF CARDIOTHORACIC SURGERY , vol.19, no.1 , 113.

Elicora, A., Yaprak Bayrak, B., Vural, C., Sezer, H. F., Erkal, S. U., & Metin, E., (2024). Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy.. JOURNAL OF CARDIOTHORACIC SURGERY , vol.19, no.1, 113.

Elicora, AYKUT Et Al. "Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy.," JOURNAL OF CARDIOTHORACIC SURGERY , vol.19, no.1, 113, 2024

Elicora, AYKUT Et Al. "Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy.." JOURNAL OF CARDIOTHORACIC SURGERY , vol.19, no.1, pp.113, 2024

Elicora, A. Et Al. (2024) . "Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy.." JOURNAL OF CARDIOTHORACIC SURGERY , vol.19, no.1, p.113.

@article{article, author={AYKUT ELİÇORA Et Al. }, title={Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapy.}, journal={JOURNAL OF CARDIOTHORACIC SURGERY}, year=2024, pages={113} }